.FDA turns down experimental MDMA-assisted treatment for post-traumatic stress disorder NBC NewsF.D.A. Declines to Authorize MDMA Treatment, Finding Even More Research The Nyc TimesFDA Rejects Ecstasy-Based Drug The Stock market JournalFDA declines to accept unique MDMA treatment to handle post-traumatic stress disorder, along with ask for even more hearing records CNNFDA turns down initially experimental to manage post-traumatic stress disorder, asking for additional study The Washington Message.